Ruzzo, A., Graziano, F., Galli, F., Galli, F., Rulli, E., Lonardi, S., . . . Magnani, M. (2017). Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients. Br J Cancer.
Παραπομπή Chicago StyleRuzzo, A., et al. "Dihydropyrimidine Dehydrogenase Pharmacogenetics for Predicting Fluoropyrimidine-related Toxicity in the Randomised, Phase III Adjuvant TOSCA Trial in High-risk Colon Cancer Patients." Br J Cancer 2017.
Παραπομπή MLARuzzo, A., et al. "Dihydropyrimidine Dehydrogenase Pharmacogenetics for Predicting Fluoropyrimidine-related Toxicity in the Randomised, Phase III Adjuvant TOSCA Trial in High-risk Colon Cancer Patients." Br J Cancer 2017.